Bajaj Healthcare Limited — Important, 17-02-2025: Updates
Bajaj Healthcare Limited's Board has approved the quarterly financial results for the quarter and nine months ended on 31 December 2024. The total income for Q3 stood at ₹12,516.59 Cr, a notable increase from ₹10,937.02 Cr in the same quarter last year. This was driven by a revenue from operations of ₹12,279.40 Cr compared to ₹10,857.25 Cr in Q3 FY23. The company reported a profit before tax of ₹1,165.29 Cr, improving from ₹632.54 Cr year-on-year. However, loss from discontinued operations was recorded at ₹324.44 Cr.
Additionally, Ms. Monica Tanwar has been appointed as Company Secretary and Compliance Officer, highlighting a strategic move to strengthen governance. The company presents a positive outlook, fueled by strong operational performance, although the ongoing management of discontinued operations may pose risks. Investors should watch closely as these developments unfold.
